Allograft and bone morphogenetic proteins: an overview

Injury

Volumn 39, Issue SUPPL.2, 2008, Pages

  Blokhuis, T J ^a   Lindner, T ^b,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allograft; BMP 2; BMP 7; BMPs; Bone grafting; Fracture healing; Non union

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BONE ALLOGRAFT; CLINICAL TRIAL; DRUG EFFECT; FRACTURE HEALING; HUMAN; NONHUMAN; PRIORITY JOURNAL; TIBIA FRACTURE; TREATMENT FAILURE;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; COMBINED MODALITY THERAPY; FRACTURE HEALING; FRACTURES, BONE; HUMANS;

EID: 51649128569     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-1383(08)70013-5     Document Type: Article

References (42)

1. Berven S., Tay B.K., Kleinstueck F.S., et al. Clinical applications of bone graft substitutes in spine surgery: consideration of mineralized and demineralized preparations and growth factor supplementation. Eur Spine J 10 Suppl 2 (2001) S169-S177
2. Buck B.E., Malinin T.I., and Brown M.D. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 240 (1989) 129-136
3. Tomford W.W. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 77 11 (1995) 1742-1754
4. Giannoudis P.V., Dinopoulos H., and Tsiridis E. Bone substitutes: an update. Injury 36 Suppl 3 (2005) S20-S27
5. Balsly CR, Cotter AT, Williams LA, et al. Effect of low dose and moderate dose gamma irradiation on the mechanical properties of bone and soft tissue allografts. Cell Tissue Bank 2008 Epub.
6. Urabe K., Itoman M., Toyama Y., et al. Current trends in bone grafting and the issue of banked bone allografts based on the fourth nationwide survey of bone grafting status from 2000 to 2004. J Orthop Sci 12 6 (2007) 520-525
7. Centers for Disease Control and Prevention C. Invasive Streptococcus pyogenes after allograft implantation - Colorado. MMWR Morb Mortal Wkly Rep 52 48 (2003) 1174-1176
8. Kainer M.A., Linden J.V., Whaley D.N., et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 350 25 (2004) 2564-2571
9. Heyligers I.C., and Klein-Nulend J. Detection of living cells in non-processed but deep-frozen bone allografts. Cell Tissue Bank 6 1 (2005) 25-31
10. Hamer A.J., Strachan J.R., Black M.M., et al. Biochemical properties of cortical allograft bone using a new method of bone strength measurement. A comparison of fresh, fresh-frozen and irradiated bone. J Bone Joint Surg Br 78 3 (1996) 363-368
11. Sandhu H.S., Grewal H.S., and Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 30 4 (1999) 685-698
12. Stevenson S., Emery S.E., and Goldberg V.M. Factors affecting bone graft incorporation. Clin Orthop Relat Res 324 (1996) 66-74
13. McAllister D.R., Joyce M.J., Mann B.J., et al. Allograft update: the current status of tissue regulation, procurement, processing, and sterilization. Am J Sports Med 35 12 (2007) 2148-2158
14. Moreau M.F., Gallois Y., Basle M.F., et al. Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. Biomaterials 21 4 (2000) 369-376
15. Deakin D.E., and Bannister G.C. Graft incorporation after acetabular and femoral impaction grafting with washed irradiated allograft and autologous marrow. J Arthroplasty 22 1 (2007) 89-94
16. Robinson D.E., Lee M.B., Smith E.J., et al. Femoral impaction grafting in revision hip arthroplasty with irradiated bone. J Arthroplasty 17 7 (2002) 834-840
17. Elting J.J., Mikhail W.E., Zicat B.A., et al. Preliminary report of impaction grafting for exchange femoral arthroplasty. Clin Orthop Relat Res 319 (1995) 159-167
18. Gie G.A., Linder L., Ling R.S., et al. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br 75 1 (1993) 14-21
19. Schreurs B.W., Bolder S.B., Gardeniers J.W., et al. Acetabular revision with impacted morsellised cancellous bone grafting and a cemented cup. A 15- to 20-year follow-up. J Bone Joint Surg Br 86 4 (2004) 492-497
20. Lohmann C.H., Andreacchio D., Koster G., et al. Tissue response and osteoinduction of human bone grafts in vivo. Arch Orthop Trauma Surg 121 10 (2001) 583-590
21. Shigeyama Y., D'Errico J.A., Stone R., et al. Commerciallyprepared allograft material has biological activity in vitro. J Periodontol 66 6 (1995) 478-487
22. Dion N., and Sim F.H. The use of allografts in musculoskeletal oncology. Instr Course Lect 51 (2002) 499-506
23. Mankin H.J., Gebhardt M.C., Jennings L.C., et al. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res 324 (1996) 86-97
24. Calori G.M., D'Avino M., Tagliabue L., et al. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury 37 Suppl 3 (2006) S43-S50
25. De Biase P., and Capanna R. Clinical applications of BMPs. Injury 36 Suppl 3 (2005) S43-S46
26. Dimitriou R., Dahabreh Z., Katsoulis E., et al. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36 Suppl 4 (2005) S51-S59
27. Giannoudis P.V., and Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury 36 Suppl 3 (2005) S47-S50
28. Kanakaris N.K., Paliobeis C., Nlanidakis N., et al. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury 38 Suppl 2 (2007) S65-S75
29. Ronga M., Baldo F., Zappala G., et al. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients. Injury 37 Suppl 3 (2006) S51-S56
30. Schmidmaier G., Schwabe P., Wildemann B., et al. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury 38 Suppl 4 (2007) S35-S41
31. Vaibhav B., Nilesh P., Vikram S., et al. Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 38 11 (2007) 1227-1235
32. Fukuroku J., Inoue N., Rafiee B., et al. Extracortical bone-bridging fixation with use of cortical allograft and recombinant human osteogenic protein-1. J Bone Joint Surg Am 89 7 (2007) 1486-1496
33. Lee F.Y., Storer S., Hazan E.J., et al. Repair of bone allograft fracture using bone morphogenetic protein-2. Clin Orthop Relat Res 397 (2002) 119-126
34. Pluhar G.E., Manley P.A., Heiner J.P., et al. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res 19 2 (2001) 308-317
35. Salkeld S.L., Patron L.P., Barrack R.L., et al. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 83-A 6 (2001) 803-816
36. Schwartz Z., Somers A., Mellonig J.T., et al. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freezedried bone allograft makes an effective composite bone inductive implant material. J Periodontol 69 12 (1998) 1337-1345
37. Anand N., Hamilton J.F., Perri B., et al. Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome. Spine 31 20 (2006) E748-E753
38. Baskin D.S., Ryan P., Sonntag V., et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 28 12 (2003) 1219-1224
39. Jones A.L., Bucholz R.W., Bosse M.J., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88 7 (2006) 1431-1441
40. Slosar P.J., Josey R., and Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J 7 3 (2007) 301-307
41. Lewandrowski K.U., Nanson C., and Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J 7 5 (2007) 609-614
42. McClellan J.W., Mulconrey D.S., Forbes R.J., et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 19 7 (2006) 483-486